Source:http://linkedlifedata.com/resource/pubmed/id/14681319
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
12
|
pubmed:dateCreated |
2003-12-18
|
pubmed:abstractText |
Cyclooxygenase is the rate-limiting enzyme that catalyzes the conversion of arachidonic acid to prostaglandins. The inducible form, cyclooxygenase-2, is known to be overexpressed in various human cancers including the colon, stomach, and urinary bladder. In this study, we evaluated the overexpression of cyclooxygenase-2 in 64 cases of breast cancer and correlated the results with clinicopathologic parameters. Immunohistochemical staining for cyclooxygenase-2 demonstrated positivity of the tumor cells in 46 of 64 cases (72%). Cyclooxygenase-2 overexpression was significantly correlated with larger tumor size and advanced clinical stage. Cyclooxygenase-2 overexpression tended to be more frequently observed in cases with presence of lymph node metastasis and in cases without expression of estrogen and progesterone; however, there was no significant correlation statistically. Nuclear and histologic grade were not well correlated with cyclooxygenase-2 overexpression. When ductal carcinoma in situ was considered separately, 32 of 42 cases (76%) were positive for cyclooxygenase-2. We conclude that cyclooxygenase-2 is up-regulated in a high proportion of breast cancers. The overexpression of cyclooxygenase-2 was associated with larger tumor size and advanced clinical stage, although lymph node status, estrogen and progesterone expression, and nuclear and histologic grade were not significantly correlated. Therefore, cyclooxygenase-2 overexpression may be a feature of the aggressive phenotype and may be useful as a prognostic indicator in breast cancer.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Cyclooxygenase 2,
http://linkedlifedata.com/resource/pubmed/chemical/Isoenzymes,
http://linkedlifedata.com/resource/pubmed/chemical/Membrane Proteins,
http://linkedlifedata.com/resource/pubmed/chemical/PTGS2 protein, human,
http://linkedlifedata.com/resource/pubmed/chemical/Prostaglandin-Endoperoxide Synthases,
http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Estrogen,
http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Progesterone
|
pubmed:status |
MEDLINE
|
pubmed:month |
Dec
|
pubmed:issn |
0893-3952
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
16
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1199-204
|
pubmed:dateRevised |
2005-11-17
|
pubmed:meshHeading |
pubmed-meshheading:14681319-Breast Neoplasms,
pubmed-meshheading:14681319-Carcinoma, Intraductal, Noninfiltrating,
pubmed-meshheading:14681319-Carcinoma in Situ,
pubmed-meshheading:14681319-Cyclooxygenase 2,
pubmed-meshheading:14681319-Female,
pubmed-meshheading:14681319-Humans,
pubmed-meshheading:14681319-Immunohistochemistry,
pubmed-meshheading:14681319-Isoenzymes,
pubmed-meshheading:14681319-Lymph Nodes,
pubmed-meshheading:14681319-Lymphatic Metastasis,
pubmed-meshheading:14681319-Membrane Proteins,
pubmed-meshheading:14681319-Neoplasm Staging,
pubmed-meshheading:14681319-Prognosis,
pubmed-meshheading:14681319-Prostaglandin-Endoperoxide Synthases,
pubmed-meshheading:14681319-Receptors, Estrogen,
pubmed-meshheading:14681319-Receptors, Progesterone
|
pubmed:year |
2003
|
pubmed:articleTitle |
Overexpression of cyclooxygenase-2 is associated with breast carcinoma and its poor prognostic factors.
|
pubmed:affiliation |
Department of Pathology, Bundang CHA Hospital, Pochon CHA University, Sungnam, Korea.
|
pubmed:publicationType |
Journal Article
|